auditory sensory epithelium occurs in a spatially and temporally highly coordinated manner. 47 7 BMP signaling is known to positively regulate Id1-3 expression in inner ear pro-sensory cells 157 (Kamaid et al., 2010; Ohyama et al., 2010) . Consistent with these previous reports, 3.5 hour 158 BMP4 treatment of E13.5 cochlear epithelia led to an increase in Id1-3 expression, which was 159 significant for Id1 and Id3, but showed no effect on Id4 expression compared to control ( Fig. 2  160   K ). In contrast, 3.5 hour Activin A treatment of E13.5 cochlear epithelia had no effect on Id1-3 161 expression but resulted in a modest, but significant decrease in Id4 expression compared to 162 control ( Fig. 2 K) . The divergent transcriptional responses to Activin A and BMP4 are likely the 163 consequence of differences in type I receptor and R-SMAD utilization. Activins commonly utilize 164 the type I receptor ALK4 (ACVR1B), which signals through SMAD2 and SMAD3, whereas 165
BMPs activate the type I receptors ALK3 (BMPR1A) and ALK6 (BMPR1B), which signal through 166 SMAD1, SMAD5 and SMAD9 activation (reviewed in (Miyazawa et al., 2002) ). Indeed, we found 167 that a 3.5-hour exposure of E13.5 cochlear epithelia to Activin A selectively stimulated the 168 phosphorylation of SMAD2/3, whereas a 3.5-hour treatment with BMP4 resulted in the 169 phosphorylation of SMAD1/5/9 (Fig. 2 J, K) . In contrast to the 24-hour Activin A treatment, the 170 3.5-hour Activin A treatment failed to significantly increase Atoh1 expression, suggesting that 171
Activin A promotes the expression of Atoh1 through indirect mechanisms. 172
173

FST inhibits auditory hair cell differentiation 174
To characterize the function of FST in cochlear development we made use of a recently 175 developed doxycycline (dox) inducible transgenic mouse line, in which a cassette encoding the 176 human FST-288 isoform is under the control of a tetracycline-responsive promoter element 177 (tetO) (Lee and McPherron, 2001 ; Roby et al., 2012) (Fig. 3 A) . In the presence of a ubiquitously 178 expressed reverse tetracycline-controlled trans-activator (rtTA), dox administration allows for 179 robust induction of the human (h) FST transgene (Fig. 3 A, B, G) . To assess the role of FST in 180 cochlear hair cell differentiation, timed pregnant females received dox beginning at E11.5 and 181 double transgenic FST over-expressing embryos (R26-FST) and single transgenic littermates 182 8 lacking the R26-M2rtTA transgene (control), were harvested three days later (E14.5). Inclusion 183 of the Atoh1-reporter transgene (Atoh1/nEGFP) allowed for the ready analysis of hair cell 184 differentiation at the time of isolation. While Atoh1-reporter positive inner hair cells were 185 detectable in the cochlear base of stage E14.5 control cochlear tissue (Fig. 3 C, E) , stage E14.5 186 FST overexpressing cochlear tissue lacked cochlear hair cells (Fig. 3 D, F (Fig. 3 H) . Activins as well as the Activin-type ligands 194
Gdf11 and myostatin are high affinity binding partners for FST (Harrington et al., 2006) . In 195 addition, FST has been shown to bind at low affinity to BMP4 and BMP7 and modulate their 196 activity (Iemura et al., 1998; Amthor et al., 2002) . These two related BMP ligands are 197 abundantly expressed in the developing cochlea and are thought to function in the specification 198 and patterning of the pro-sensory domain (Ohyama et al., 2010) . To determine whether FST 199 overexpression inhibits BMP signaling in the developing cochlea, we administered dox at E12.5, 200
and two days analyzed P-SMAD2/3 and P-SMAD1/5/9 proteins in acutely isolated control and 201 FST overexpressing cochlea epithelia. Our western blot analysis revealed that P-SMAD2/3 202 protein levels were reduced in FST overexpressing cochlear epithelia compared to control 203 cochlear epithelia. However, FST overexpression had little to no effect on P-SMAD1/5/9 protein 204 levels, indicating that FST overexpression in the developing cochlea selectively disrupts type signaling (Fig. 3 E) . 206
To determine whether exogenous Activin A can rescue the FST mediated delay in hair 207 cell differentiation, we monitored Atoh1-reporter expression in cultures of E13.5 FST 208 9 overexpressing (R26-FST) and single transgenic wild type cochlear tissue treated with or 209 without Activin A (Fig. 4 A) . Consistent with our earlier findings, we observed that hair cell 210 differentiation occurred significantly earlier in Activin A-treated wild type cochlear explants 211 compared to untreated wild type cochlear explants (Fig. 4 C, B, N) . Conversely, the onset of hair 212 cell differentiation was significantly delayed in untreated FST overexpressing cochlear explants 213 compared to untreated wild type cochlear explants (Fig. 4 F, H, N) . However, these defects 214 were almost completely abolished when Activin A treatment and FST overexpression were 215 combined and no significant differences in the onset (Fig. 4 F, I , N In the mammalian cochlea, cell cycle exit of pro-sensory cells occurs in a highly 222 synchronized manner. Pro-sensory cells located in the cochlear apex withdraw from the cell 223 cycle first, followed by more basally located pro-sensory cells (Ruben, 1967; Lee et al., 2006) . 224
To determine whether FST antagonizes pro-sensory cell cycle withdrawal, we injected timed 225 pregnant dams with the thymidine analog EdU at stage E13.5, which in mice corresponds to the 226 peak of pro-sensory cell cycle withdrawal, and analyzed hair cell and supporting cell-specific 227
EdU incorporation in FST overexpressing embryos and control littermates five days later (stage 228 E18.5). Hair cells were identified by their native EGFP (Atoh1/nEGFP) expression as well as by 229 immuno-staining for the hair cell-specific protein myosinVIIa (Myo7a); supporting cells were 230 identified by SOX2 immuno-staining. Classification of cell subtypes was based on their location 231 within the sensory epithelium. As expected we found that basally located hair cells and their 232 surrounding supporting cells incorporated EdU at high frequency in both control (Fig. 5 A) and 233 FST overexpressing cochlear tissue (Fig. 5 D) . However, whereas in control cochlear tissue 234 10 supporting cells and hair cells located further apically (mid and apex) showed little to no EdU 235 incorporation ( Fig. 5 B, C) , their counterparts in FST overexpressing cochleae exhibited robust 236
EdU incorporation (Fig. 5 E, F inner hair cell phenotype was most severe in the base of the cochlea; inner hair cell density was 275 increased nearly 2.5-fold compared to controls and was accompanied by an increase in 276 surrounding inner phalangeal cells (Fig. 7 B, D were missing, resulting in reduced outer hair cell and Deiters' cell densities (Fig. 7 D, G, H) . 281
Furthermore, differentiation/maturation of the auditory sensory epithelium was severely delayed 282 in response to FST overexpression. At stage E18.5, the basal-to-apical wave of differentiation 283 has reached the cochlear apex. The initially multilayered auditory sensory epithelium is largely 284 thinned to a two-layered sensory epithelium and is near its final length. Moreover, hair cells, 285 including hair cells located in the cochlear apex, have formed actin-rich apical protrusions, so12 called stereocilia (see Fig. 7 C, E). Consistent with a severe delay in pro-sensory cell 287 differentiation, hair cells in FST overexpressing cochlear tissue had less developed stereocilia 288 than their wild type counterparts, and apical hair cells lacked stereocilia completely (Fig. 7 C-F) . 289
Moreover, our analysis revealed that the auditory sensory epithelia of FST overexpressing 290 cochleae consisted of more than two epithelial layers (see Fig. 5 A-F) and were 30% shorter 291 compared to control sensory epithelia obtained from littermates (dox E11.5, harvest E18.5: 292 control = 5.14± 0.04 mm, R26-FST =3.65 ± 0.13 mm, n=5, p=0.0002). 293
FST induction one day later at~ E13.0 (dox E12.5), had no effect on the length of the 294 auditory sensory epithelium (dox E12.5, harvest E17.5: control = 4.13± 0.17 mm, R36-FST 295 =3.99 ± 0.12 mm, n=3, p=0.5425), but we continued to observe ectopic inner hair cells in FST 296 overexpressing cochleae, with the highest number of ectopic hair cells found in the basal portion 297 of the auditory sensory epithelium, as well as short stretches of sensory epithelium with only 2 298 rows of outer hair cells (Fig. 7 J, M) . Furthermore, we found that hair cell stereocilia in FST 299 overexpressing cochlea had a less mature phenotype compared to their counterparts in control 300 cochlear tissue, indicating that FST induction as late as ~E13.0 causes a delay in hair cells 301 differentiation/maturation (Fig. 7 I-L) . 302
The formation of inner hair cells is regulated by a complex interplay of various signaling 303 pathways including Notch, Wnt and BMP signaling (reviewed in (Groves and Fekete, 2012)). In 304 particular, a recent study revealed that inhibition of BMP signaling using dorsomorphin results in 305 the overproduction of inner hair cells in cochlear explants (Munnamalai and Fekete, 2016) . (Fig. 7 N-P (Fig. 7 Q-S, T) . Furthermore, consistent with a delayed onset of hair 320 cell differentiation, hair cell stereocilia in the base, mid and apex of Inhba mutant cochlear tissue 321 had a less mature phenotype compared to control cochlear tissue ( Hes1 GCT TCA GCG AGT GCA TGA AC  CGG TGT TAA CGC CCT CAC A  492   20   Hes6 CCA TCG ATG CCA CTG TCT CA  GCA GCG GCA TGG ATT CTA G  493   Id1  GAA CGT CCT GCT CTA CGA CAT G  TGG GCA CCA GCT CCT TGA  494   Id2  AAG GTG ACC AAG ATG GAA ATC CT  CGA TCT GCA GGT CCA AGA TGT  495   Id3  GAG CTC ACT CCG GAA CTT GTG  CGG GTC AGT GGC AAA AGC  496   Id4  TGC GAT ATG AAC GAC TGC TAC A  TTG TTG GGC GGG ATG Immun-Blot PVDF membrane (Bio-rad) by electrophoresis. Membranes were blocked in 5% no-507 fat dry milk in TBST and immunoblotted with rabbit anti-P-Smad2/3 (1:1,000 Cell Signaling, 508 no.8828), P-Smad1/5/9 1:1,000 (Cell Signaling, no.13820) and mouse anti-β-actin 1:1,000 509 (Santa Cruz, no.SC-47778). HRP-conjugated secondary antibodies from Jackson Immuno 510
Research were used at a concentration of 1:10,000 (goat anti-rabbit IgG, no.111-035-003; 511 
